Safety and Tolerability of Oral CM082 in Patients With wAMD

NCT03710863 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Macular Degeneration

Interventions

DRUG: CM082

Sponsor

AnewPharma

Collaborators

[object Object]